2020-02-14T15:51:26-06:00 2019-03-31 PHILLIP GROFF - KPMG LLP 345 Park Avenue New York NY 101540102 990 2018-04-01 131949477 NEW YORK BLOOD CENTER % JOON MOON NEWY 2125703100 310 East 67th Street New York NY 10065 JOON MOON INTERIM CFO 2125703016 2020-02-12 true PHILLIP GROFF P01247783 2127589700 167.68.102.5 13407320200455000055 2020-02-14 P 3334E7B7F03F731422ECC73C4D529CE40FFEDC8C 3334E7B7F03F731422ECC73C4D529CE40FFEDC8C 2018 2020-09-23 17:36:50Z Dr Christopher Hillyer 310 East 67th Street New York NY 10065 505009741 false X nybloodcenter.org X 1959 NY AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. 23 22 1266 200 312306 12883405 13590606 321238027 346596532 17822718 30382930 669197 627078 352613347 391197146 153008 118751 0 0 119797851 137296283 0 0 185450 242788202 250504682 362739061 387919716 -10125714 3277430 555190471 553444220 70934612 78703573 484255859 474740647 X AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NYBC OPERATES UNDER A FOUR-PART MISSION. FOR MORE INFORMATION, SEE SCH. O AND PART III, 4A-C. false false 186523946 118751 197162103 BLOOD SERVICES: THE COLLECTION AND PROCESSING OF BLOOD PRODUCTS, AND THE DISTRIBUTION OF THESE PRODUCTS TO HOSPITALS IN THE GREATER NY AREA AND NATIONWIDE FOR TRANSFUSIONS TO PATIENTS. 148050581 148858406 MEDICAL PROGRAMS: PROGRAMS INCLUDE (1) CLINICAL SERVICES (INCLUDING TRANSFUSION THERAPY SERVICES); (2) BONE MARROW PROGRAM; AND (3) HEMOPHILIA SERVICES CONSORTIUM. NATIONAL CORD BLOOD PROGRAM: THE COLLECTION, PROCESSING AND STORAGE OF CORD BLOOD UNITS AND THE DISTRIBUTION OF THESE UNITS FOR TREATMENT OR FOR RESEARCH PURPOSES. 14480550 576023 RESEARCH PROGRAM: THE NEW YORK BLOOD CENTER OPERATES A WIDE-RANGING PROGRAM OF RESEARCH INTO THE PROPERTIES OF BLOOD AND BLOOD RELATED DISEASES. 349055077 true true false true false false false false false false true true true false true true false true false false true false false false false false false true true true false false false false false false false false false false false false false true true true false false true 233 0 true 1266 true true true false false false false false false false false false false false X 23 22 true false true false false false false true true false false true true true true true true true true false CT NJ NY OK X JOON MOON 2125703016 310 EAST 67TH STREET NEW YORK NY 10065 PHILIP FALIVENE TRUSTEE 1.0 0.0 X 0 0 0 THOMAS HEANEY TRUSTEE 1.0 0.0 X 0 0 0 MARK SCHMIDTLEIN VICE CHAIR 1.0 3.0 X 0 0 0 ROBERT A SCHWARTZ TRUSTEE 2.0 2.0 X 0 0 0 MARC KRAMER CHAIR 1.0 0.0 X 0 0 0 DAVID TENDLER CHAIR, BOARD OF TRUSTEES 5.0 3.0 X 0 0 0 STEPHEN D WURTZLER TRUSTEE 1.0 1.0 X 0 0 0 PAUL M TORGERSON TRUSTEE 1.0 1.0 X 0 0 0 JENNIFER JONES-AUSTIN TRUSTEE 1.0 0.0 X 0 0 0 AARON R MARCU TRUSTEE 2.0 0.0 X 0 0 0 JOHN MULLEN TRUSTEE (END 10/28/2018) 2.0 0.0 X 0 0 0 CHRISTOPHER HILLYER MD PRESIDENT & CEO 50.0 6.0 X X 1689851 0 101346 DAVID DRISCOLL TRUSTEE 1.0 0.0 X 0 0 0 JOHN FERRETTI TRUSTEE 1.0 0.0 X 0 0 0 ARIEL FISHMAN TRUSTEE 1.0 0.0 X 0 0 0 CLAIRE POMEROY TRUSTEE 1.0 0.0 X 0 0 0 CHARLES REPPUCCI TRUSTEE 1.0 1.0 X 0 0 0 JOHN ROSENTHAL TRUSTEE 1.0 0.0 X 0 0 0 MARK SHAW TRUSTEE 1.0 1.0 X 0 0 0 FAYE WATTLETON TRUSTEE 1.0 0.0 X 0 0 0 OWEN GARRICK TRUSTEE 1.0 0.0 X 0 0 0 THERESA RAGOZINE TRUSTEE 1.0 0.0 X 0 0 0 AVERY AUGUST TRUSTEE (BEGIN 10/28/2018) 1.0 0.0 X 0 0 0 PETER LOPEZ TRUSTEE (BEGIN 8/1/2018) 1.0 0.0 X 0 0 0 C ELIZABETH GIBSON CHIEF FINANCIAL OFFICER 50.0 0.0 X 494706 0 55685 BETH SHAZ MD EVP, CHIEF MEDICAL OFFICER 50.0 6.0 X 602882 0 71251 ELIZABETH MCQUAIL EVP, CHIEF OPERATING OFFICER 50.0 6.0 X 665221 0 85386 BETSY JETT SVP, QUAL & REGULATORY AFFAIRS 50.0 0.0 X 413964 0 38251 JORDANA G SCHWARTZ SVP, GENERAL COUNSEL & SECR 50.0 6.0 X 441734 0 61082 BERNADETTE TISO DEPUTY GENERAL COUNSEL 50.0 6.0 X 241839 0 49654 DORIANE GLORIA VP - HUMAN RESOURCES 50.0 0.0 X 128900 0 36232 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFF 50.0 0.0 X 323320 0 53687 DAVID GRAHAM EXECUTIVE DIRECTOR - CBCKC 50.0 0.0 X 248494 0 49215 Patricia Killeen VP-ENTERPRISE BLOOD OPS OPT 50.0 0.0 X 280241 0 42536 Donna Strauss VP - ENTERPRISE LAB SERVICE 50.0 0.0 X 292087 0 43483 PABLO RUBINSTEIN SVP - NCBP 50.0 0.0 X 374647 0 38921 MOHANDAS NARLA VP - LFRKI 50.0 0.0 X 373612 0 41469 ROBERT PURVIS SVP - CUSTOMER SERVICE 50.0 0.0 X 371862 0 56921 CONNIE WESTHOFF EXEC DIR - IMMUNOHEMATOLOGY 50.0 0.0 X 325727 0 39895 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 50.0 0.0 X 328432 0 50764 7597519 0 915778 133 false true false ATOS IT SOLUTIONS AND SERVICE PO BOX 710878 COLUMBUS OH 43271 IT SERVICES 1984135 ALL SYSTEMS MESSENGER 3391 MERRICK ROAD WANTAGH NY 11793 MESSENGER 1527761 ATALIAN GLOBAL SERVICES 417 FIFTH AVENUE NEW YORK NY 10016 SECURITY 880018 INCEPT CORPORATION 4150 BELDEN VILLAGE STREET CANTON OH 44718 DONOR MARKETING 1633884 ORACLE AMERICA INC PO BOX 203448 DALLAS TX 75320 SOFTWARE 1087355 5 12313557 1277049 5844 13590606 BLOOD SERVICES 621500 197162103 197162103 MEDICAL PROGRAMS 621500 148858406 148858406 RESEARCH PROGRAM 621500 576023 576023 346596532 11279981 312306 10967675 0 3074 3074 624004 624004 0 624004 624004 132675000 240544 113568701 243894 19106299 -3350 19102949 19102949 0 0 0 0 0 0 0 0 0 0 391197146 346596532 312306 30697702 90276 90276 28475 28475 0 0 6731779 6731779 0 98315922 90967296 7271947 76679 5316100 4784490 531610 16988357 15110874 1856872 20611 9944125 9064889 873738 5498 1437719 1437719 1512506 188379 1324127 420845 420845 197900 197900 0 1442352 1442352 1453976 640879 744259 68838 133543 53561 79982 1443969 1321524 122445 2300467 2300467 0 4675748 4572217 103531 318255 241398 76857 0 55000 55000 834454 834454 0 11546795 8735802 2810993 1997661 1817854 179807 SUPPLIES 149566866 148841627 725239 TESTING FEES 25196580 25196580 MGMT FEE-HEMOPHILIA CONSORTIUM 11728736 11728736 SERVICES PURCHASED 17071434 11454920 5605039 11475 17169876 13127946 4039581 2349 387919716 349055077 38679189 185450 3244172 14654899 15178627 31696189 0 0 41145782 50490933 0 0 0 0 0 0 42170031 36199935 3564843 3287616 217111455 164175378 46304057 52936077 240476593 232009421 51335769 38698518 111770597 91418230 0 0 0 2052402 555190471 553444220 47735504 59253956 0 0 7638061 6204801 0 0 0 0 0 0 12917131 10870772 0 0 2643916 2374044 70934612 78703573 X 483491255 473907647 764604 833000 0 0 484255859 474740647 555190471 553444220 X 3277430 -17074202 4281560 X false true X true true true X 10435452 14044399 12829969 12883405 13590606 63783831 298464704 312108036 319980728 321238027 346596532 1598388027 0 0 0 308900156 326152435 332810697 334121432 360187138 1662171858 136261 490440 777863 146193 104344 1655101 0 136261 490440 777863 146193 104344 1655101 1660516757 9665929 8777204 8457352 8505075 11907059 47312619 0 9665929 8777204 8457352 8505075 11907059 47312619 0 0 318566085 334929639 341268049 342626507 372094197 1709484477 0.97135 0.97184 0.02768 0.02717 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 197900 197900 387721816 387919716 1000000 250000 1000000 1000000 1000000 1000000 4000000 6000000 138869 192212 178101 197900 707082 250000 250000 250000 250000 1000000 1500000 5838174 5838174 40110723 36466583 3644140 44772722 19972549 24800173 71790403 57635821 14154582 54599433 50100425 4499008 52936077 PRIVATE INVESTMENT FUNDS 17362614 F HEDGE FUNDS 21335904 F 38698518 INTEREST IN IBR 38196615 F INTEREST IN BBD 26819898 F INTEREST IN RIBC 26401717 F 91418230 0 RESERVE FOR CLAIMS 1000000 FMV OF INTEREST RATE SWAP AGRE 1374044 2374044 X UNCERTAIN TAX POSITIONS SCHEDULE D, PART X, LINE 2 THE ORGANIZATION HAS BEEN DETERMINED BY THE INTERNAL REVENUE SERVICE TO BE A NOT-FOR-PROFIT CORPORATION, EXEMPT FROM FEDERAL INCOME TAX UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). AS A NOT FOR-PROFIT CORPORATION, NYBC IS ALSO EXEMPT FROM STATE AND LOCAL INCOME TAXES. THE ORGANIZATION RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO THE ORGANIZATION'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. THE ORGANIZATION DID NOT RECOGNIZE ANY UNRELATED BUSINESS INCOME TAX LIABILITY FOR THE YEARS ENDED MARCH 31, 2019 AND 2018. Central America and the Caribbean 0 0 Investments 2429650 Central America and the Caribbean 0 0 Investments 793986 0 0 0 0 3223636 3223636 true false true true true false true AABB NBF 8101 Glenbrook Rd Bethesda MD 20814 362384118 501(c)(3) 25000 GENERAL SUPPORT 1 COLLEGE SCHOLARSHIPS 136 90276 PART I, LINE 2 NYBC HAS PROVIDED FINANCIAL ASSISTANCE, RATHER THAN GRANTS, TO THE ORGANIZATIONS LISTED IN PART I. THIS ASSISTANCE IS CONSISTENT WITH NYBC'S CHARITABLE MISSION. PART III, LINE 1 COLLEGE SCHOLARSHIPS AWARDED TO STUDENTS WHO VOLUNTEER THEIR TIME AT BLOOD DRIVES IN THE FURTHERANCE OF NYBC'S MISSION. X X X X X false true false false false false false true false CHRISTOPHER HILLYER MD PRESIDENT & CEO 1058451 600000 31400 68250 33096 1791197 C ELIZABETH GIBSON CHIEF FINANCIAL OFFICER 444834 40576 9296 31516 24169 550391 BETH SHAZ MD EVP, CHIEF MEDICAL OFFICER 529382 55000 18500 38309 32942 674133 ELIZABETH MCQUAIL EVP, CHIEF OPERATING OFFICER 595721 51000 18500 60317 25069 750607 BETSY JETT SVP, QUAL & REGULATORY AFFAIRS 373956 35000 5008 26290 11961 452215 JORDANA G SCHWARTZ SVP, GENERAL COUNSEL & SECR 396670 37874 7190 28449 32633 502816 PABLO RUBINSTEIN SVP - NCBP 374647 0 0 27000 11921 413568 MOHANDAS NARLA VP - LFRKI 367170 0 6442 18900 22569 415081 ROBERT PURVIS SVP - CUSTOMER SERVICE 321232 32130 18500 24135 32786 428783 DORIANE GLORIA VP - HUMAN RESOURCES 80250 32450 16200 18900 17332 165132 MICHELE SCAGGIANTE VP - CHIEF INFORMATION OFF 294891 26329 2100 18900 34787 377007 CONNIE WESTHOFF EXEC DIR - IMMUNOHEMATOLOGY 310358 15369 0 18900 20995 365622 BRUCE SACHAIS EXECUTIVE MEDICAL DIRECTOR 313012 15420 0 18900 31864 379196 DAVID GRAHAM EXECUTIVE DIRECTOR - CBCKC 237627 10867 0 17269 31946 297709 BERNADETTE TISO DEPUTY GENERAL COUNSEL 230303 11536 0 16867 32787 291493 Patricia Killeen VP-ENTERPRISE BLOOD OPS OPT 267885 12356 0 18900 23636 322777 Donna Strauss VP - ENTERPRISE LAB SERVICE 279603 12484 0 27000 16483 335570 SCHEDULE J, PART I, LINE 4B THE INDIVIDUALS LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. PAYMENTS WERE VESTED AND RECEIVED IN 2018 AND INCLUDABLE IN INCOME. - Doriane Gloria - $16,200 - ELIZABETH MCQUAIL - $18,500 - C. ELIZABETH GIBSON - $9,296 - BETH SHAZ - $18,500 - MOHANDAS NARLA - $6,442 - JORDANA SCHWARTZ - $7,190 - BETSY JETT - $5,008 - MICHELE SCAGGIANTE - $2,100 - ROBERT PURVIS - $18,500 THE INDIVIDUAL LISTED BELOW PARTICIPATED IN A SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN. NO PAYMENTS WERE RECEIVED IN 2017 AND NO AMOUNTS INCLUDABLE IN INCOME AS THEY WERE NOT VESTED AND ARE SUBJECT TO A SUBSTANTIAL RISK OF FORFEITURE. - CHRISTOPHER HILLYER SCHEDULE J, PART I, LINE 7 Upon the organization achieving certain budget thresholds, executives other than the CEO were eligible for merit bonuses of up to 5% or 10% of their annual base salaries, determined by their achieving performance benchmarks established by senior management and approved by the Compensation Committee of the Board. MISSION STATEMENT PART I, LINE 1 AND PART III, LINE 1 AS ONE OF THE MOST PREEMINENT AND COMPREHENSIVE BLOOD CENTERS IN THE WORLD, NEW YORK BLOOD CENTER OPERATES UNDER A FOUR-PART MISSION. SPECIFICALLY, NYBC EXISTS: -TO PROVIDE THE HIGHEST QUALITY BLOOD AND STEM CELL PRODUCTS AND RELATED MEDICAL AND CONSULTATIVE SERVICES TO HOSPITALS AND PATIENTS PRIMARILY IN THE GREATER NEW YORK METROPOLITAN AREA AND NATIONWIDE -TO CONDUCT THE HIGHEST QUALITY, NOVEL AND INNOVATIVE RESEARCH IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING AND TRANSFUSION MEDICINE, AND CELLULAR THERAPIES, THUS ADVANCING THESE FIELDS AND POSITIVELY IMPACTING THE PUBLIC HEALTH -TO DEVELOP PRODUCTS, TECHNOLOGIES, AND SERVICES IN THE FIELDS OF HEMATOLOGY, BLOOD BANKING, AND TRANSFUSION MEDICINE AND CELLULAR THERAPIES, WITH THE POTENTIAL TO HAVE WORLDWIDE HUMANITARIAN IMPACT -TO TRAIN THE NEXT GENERATION OF LEADERS IN EACH OF THESE FIELDS GOVERNING BODY PART VI, SECTION A, LINE 1A THE BOARD MAY DESIGNATE STANDING COMMITTEES FROM AMONG ITS MEMBERS. THESE COMMITTEES INCLUDE AN EXECUTIVE COMMITTEE, COMPRISED OF A CHAIR, VICE CHAIR, AND AT LEAST THREE ADDITIONAL MEMBERS OF THE BOARD. THE EXECUTIVE COMMITTEE MAY EXERCISE BOARD POWERS IN BETWEEN MEETINGS OF THE BOARD. PART VI, SECTION A, LINE 4 BY-LAWS UPDATED TO STREAMLINE COMPOSITION, CLARIFY CERTAIN PRACTICES, AND CONFORM TO RECENT CHANGES IN THE APPLICABLE STATE NOT-FOR-PROFIT LAW. OFFICER, DIRECTOR, TRUSTEE, OR KEY EMPLOYEE BUSINESS RELATIONSHIP PART VI, SECTION A, LINE 2 Christopher Hillyer, Elizabeth McQuail, Mark Schmidtlien, Jordana Schwartz, Beth Shaz, David Tendler, Bernadette Tiso, Stephen Wurtzler: BUSINESS RELATIONSHIP PROCESS OF FORM 990 REVIEW BY GOVERNING BODY PART VI, LINE 11A FOLLOWING COMPLETION OF THE FINANCIAL AUDIT, THE FORM 990 IS FINALIZED BY MANAGEMENT, REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM, AND REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD. THE FINAL FORM 990 IS THEN CIRCULATED TO THE FULL BOARD FOR REVIEW AND APPROVAL AT ITS ANNUAL MEETING. COMPLIANCE WITH CONFLICT OF INTEREST POLICY PART VI, LINE 12C AT THE BEGINNING OF EACH NEW FISCAL YEAR, AND ON AN AS-NEEDED BASIS, THE TAXPAYER REQUIRES ALL TRUSTEES, OFFICERS, KEY EMPLOYEES, AND SENIOR EXECUTIVES TO COMPLETE AND SIGN A STATEMENT DISCLOSING ANY ACTUAL OR APPARENT CONFLICT OF INTEREST. THESE STATEMENTS ARE REVIEWED BY THE AUDIT COMMITTEE OF THE BOARD, AS WELL AS BY THE CEO AND THE GENERAL COUNSEL. THE BOARD ULTIMATELY WILL DETERMINE WHETHER ANY CONFLICT OF INTEREST EXISTS AND, IF SO, IT APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE AND DETERMINE HOW TO MANAGE ANY SUCH CONFLICT. IN ADDITION, THE TAXPAYER MAINTAINS A GENERAL CONFLICT OF INTEREST POLICY THAT APPLIES TO ALL EMPLOYEES. PROCESSES FOR DETERMINING COMPENSATION PART VI, LINE 15 THE TAXPAYER'S PROCESS FOR DETERMINING COMPENSATION OF ITS CEO INCLUDED REVIEW AND APPROVAL BY THE INDEPENDENT COMPENSATION AND EXECUTIVE COMMITTEES OF THE BOARD AND BY THE FULL BOARD, AS WELL AS ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, AND FORMS 990 OF OTHER ORGANIZATIONS. ALL COMPENSATION REVIEW PROCESSES ARE CONTEMPORANEOUSLY DOCUMENTED. FOR DETERMINING COMPENSATION OF ITS OTHER OFFICERS AND ITS KEY EMPLOYEES, THE TAXPAYER USED ANALYSES BY AN INDEPENDENT COMPENSATION CONSULTANT, REFERENCE TO COMPENSATION SURVEYS AND COMPARABILITY DATA, REVIEW BY THE CEO AND APPROVAL BY THE INDEPENDENT COMPENSATION COMMITTEE OF THE BOARD. PUBLIC AVAILABILITY OF INFORMATION PART VI, LINE 19 THE TAXPAYER MAKES ITS FINANCIAL STATEMENTS AVAILABLE UPON REQUEST, AND ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND CODE OF CONDUCT AVAILABLE BOTH UPON REQUEST AND ON ITS WEBSITE. OTHER CHANGES IN NET ASSETS PART XI, LINE 9 UNREALIZED GAIN ON SWAP AGREEMENT -------------269,871 CHANGE IN INVESTMENT TO AFFILIATES ---------(4,011,689) TOTAL ---------------------------------------4,281,560 COMMUNITY BLOOD CENTER OF GREATER KANSAS CITY ACQUISITION ON AUGUST 1, 2014, NYBC BECAME THE SOLE MEMBER OF COMMUNITY BLOOD CENTER OF KANSAS CITY (CBC), A SECTION 501(C)(3) EXEMPT ORGANIZATION WHOSE EXEMPT PURPOSE IS TO COLLECT, PROCESS, TEST, STORE, AND DISTRIBUTE HUMAN BLOOD IN THE GREATER KANSAS CITY, MO AREA. NO CASH CONSIDERATION WAS EXCHANGED AT THE CLOSING OF THE ACQUISITION OF CBC BUT NYBC HAS RECOGNIZED ITS INTEREST IN CBC BY APPLYING THE ACQUISITION METHOD OF ACCOUNTING. EFFECTIVE APRIL 1, 2018, CBC BECAME AN OPERATING DIVISION OF NYBC. Innovative Blood Resources Acquisition on August 1, 2017, NYBC became the sole member of Innovative Blood Resources (IBR), a section 501( c)(3) exempt organization whose exempt purpose is to collect, process, test and distribute human blood in St. Paul, Duluth, Minnesota, and Lincoln, Nebraska. No cash consideration was exchanged at the closing of the acquisition of IBR but NYBC has recognized its interest in IBR by applying the acquisition method of accounting. Blood Bank of Delmarva Acquisition On August 1, 2017 (the Acquisition Date), NYBC closed on the acquisition Blood Bank of Delmarva (BBD) by becoming the sole corporate member of BBD (the Transaction). BBD is a general not for profit corporation, organized to serve the community by meeting the needs of patients, hospitals and members for safe, high quality blood products and related services for the 13 county area encompassing the Delmarva Peninsula and beyond. No cash consideration was exchanged at the closing of the Transaction. NYBC accounted for this business combination by applying the acquisition method. Rhode Island Blood Center Acquisition On July 1, 2017 (the Acquisition Date), NYBC closed on the acquisition Rhode Island Blood Center (RIBC) by becoming the sole corporate member of RIBC (the Transaction). RIBC is a State of Rhode Island and Providence Plantations general not for profit corporation, organized for the purpose of collecting and distributing human blood and blood products for the hospitals of Rhode Island while also serving customers in various states. No cash consideration was exchanged at the closing of the Transaction. NYBC accounted for this business combination by applying the acquisition method. INNOVATIVE BLOOD RESOURCES 737 PELHAM BLVD ST PAUL MN 55114 410693869 BLOOD CENTER MN 501 (C) (3) 10 NY BLOOD CTR true RHODE ISLAND BLOOD CENTER 405 PROMENADE STREET PROVIDENCE RI 02908 050317817 BLOOD CENTER RI 501(C)(3) 10 NY BLOOD CTR true BLOOD BANK OF DELMARVA 100 HYGEIA DRIVE NEWARK DE 19713 510078596 BLOOD CENTER DE 501(C)(3) 10 NY BLOOD CTR true false false false false false true true false false false true false false true false false false false INNOVATIVE BLOOD RESOURCES g 86093 FMV CASH PAID INNOVATIVE BLOOD RESOURCES h 9386040 FMV CASH PAID INNOVATIVE BLOOD RESOURCES L 1500000 FMV CASH PAID RHODE ISLAND BLOOD CENTER L 600000 FMV CASH PAID RHODE ISLAND BLOOD CENTER G 262772 FMV CASH PAID RHODE ISLAND BLOOD CENTER H 17411267 FMV CASH PAID BLOOD BANK OF DELMARVA L 600000 FMV CASH PAID BLOOD BANK OF DELMARVA G 324772 FMV CASH PAID BLOOD BANK OF DELMARVA H 270022 FMV CASH PAID